119 related articles for article (PubMed ID: 6092738)
1. [Antibacterial activity of MT-141 against anaerobic bacteria].
Watanabe T; Hara T; Kasai T; Ishii T; Miyauchi K; Date H; Jinzaki M; Shindo H; Matsugami A; Goi H
Jpn J Antibiot; 1984 Jun; 37(6):1058-69. PubMed ID: 6092738
[TBL] [Abstract][Full Text] [Related]
2. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
[TBL] [Abstract][Full Text] [Related]
4. [Activity of cefotetan against anaerobic bacteria].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefotetan against anaerobic bacteria.
Dias MB; Jacobus NV; Tally FP; Gorbach SL
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):359-63. PubMed ID: 3457672
[TBL] [Abstract][Full Text] [Related]
6. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of cefminox against anaerobes.
Watanabe K; Sawa K; Bunai M; Ueno K
J Antibiot (Tokyo); 1985 May; 38(5):649-60. PubMed ID: 3874857
[TBL] [Abstract][Full Text] [Related]
8. Activity of cefmetazole against anaerobic bacteria.
Cornick NA; Jacobus NV; Gorbach SL
Antimicrob Agents Chemother; 1987 Dec; 31(12):2010-2. PubMed ID: 3481541
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
Shafran SD; Wong J; Chow AW
Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
[TBL] [Abstract][Full Text] [Related]
10. Effect of aspoxicillin on anaerobic bacteria.
Ueno K; Watanabe K; Bunai M; Kobayashi T; Aoki M; Maezawa I; Sakuma Y; Yoshida H; Yamaguchi T
Jpn J Antibiot; 1985 Jun; 38(6):1516-28. PubMed ID: 3850132
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activities of MT-141, a new semisynthetic cephamycin, compared with those of five cephalosporins.
Inouye S; Goi H; Watanabe T; Hara T; Miyauchi K; Yoshida T; Kazuno Y; Kadosawa H; Hirano F; Kawaharajo K
Antimicrob Agents Chemother; 1984 Nov; 26(5):722-9. PubMed ID: 6440478
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600
[TBL] [Abstract][Full Text] [Related]
13. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefbuperazone against anaerobic bacteria.
Wexler H; Carter WT; Harris BH; Finegold SM
Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics.
Kasai T; Hara T; Tamura A; Kazuno Y; Inouye S; Goto S; Kuwahara S
J Antimicrob Chemother; 1985 Jun; 15(6):701-14. PubMed ID: 3928575
[TBL] [Abstract][Full Text] [Related]
16. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
Aldridge KE
Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
Werner H; Kuchenbecker K; Hammann R
Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
[TBL] [Abstract][Full Text] [Related]
18. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
19. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
Werner H; Kuchenbecker K; Hammann R
Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
